alexa Abstract | Antitumour Activity Of Pulmbagin Against Dalton's Ascitic Lymphoma

Indian Journal of Pharmaceutical Sciences
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Research Paper Open Access


The antitumour activity of plumbagin (2-methyl 5-hydroxy, 1,4 napthoquinone) has been evaluated against Dalton's ascitic lymphoma (DAL) in Swiss albino mice. A significant enhancement of mean survival time of Plumbagin treated tumour bearing mice was found with respect to control group. Plumbagin treatment was found to enhance peritoneal cell counts. When these Plumbagin treated animals underwent I. p. inoculation with DAL cells, tumour cell growth was found to be inhibited. At 14 days after transplantation, Plumbagin treated groups were able to reverse the changes in the haemotological parameters, protein and PCV consequent to tumour inoculation.

To read the full article Peer-reviewed Article PDF image

Author(s): S Kavimani R Ilango M Madheswaran B Jayakar Malaya Gupta U K Majumdar

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version